Stem cells stir EC research funding debate:
This article was originally published in Clinica
The European Research Council has agreed to allow EU funds to be used for embryonic stem cell research, subject to the applicable legislation in the individual member states. The decision, already approved by the European Commission and the European Parliament (see Clinica No 986, p 4), was ratified at last week's meeting to approve the VI Research Framework Programme 2002-06. The ethical issues surrounding stem cell research remain a "particular focus of debate", according to the minutes of the meeting. Other issues included a proposed budget of E2.2 billion ($2.5 billion) for genomics and biotechnology, E1.15 billion for advanced genomics and its healthcare applications, and E1.05 billion to "tackle the principal diseases".
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.